Dr. Francis Mervan Gress Jr., M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10022 Lake Occoquan Dr, Manassas, VA 20111 Phone: 703-581-2783 |
Jeffrey J Skovronsky, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 8700 Sudley Rd, Manassas, VA 20110 Phone: 703-369-8484 |
Dr. Robert J Van Kirk Jr., MD Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 8700 Sudley Rd, Manassas, VA 20110 Phone: 703-369-8484 |
Jocelyn S Posthumus, MD Pathology - Forensic Pathology Medicare: Accepting Medicare Assignments Practice Location: 10850 Pyramid Pl, Suite 121, Manassas, VA 20110 Phone: 703-530-2600 |
Claudine Ann Morcos, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 8709 Professional Pl Ste B, Manassas, VA 20110 Phone: 703-365-2517 |
Dr. David A Summerville, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 8700 Sudley Rd, Manassas, VA 20110 Phone: 703-369-8492 |
News Archive
A new patient survey can show improvements in the quality of patient decision-making about whether or not to undergo surgery for a herniated disc, reports a study in the August 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The Pittsburgh Protocol is unique in utilizing bone marrow cells to enable reduction of the need for multiple anti-rejection drugs after transplantation. The University of Pittsburgh Medical Center is currently the only transplantation center in the world to offer it. An early report of the initial experience with the "Pittsburgh Protocol" in three recipients of upper extremity transplants was presented during the 2010 Annual Clinical Congress of the American College of Surgeons.
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
Despite what working women may feel on a bad day, the very act of having to juggle career, motherhood and being a partner may actually be keeping them healthy.
› Verified 7 days ago